Zurueck zur Suche

Reporte zur Charge U8135AE

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

1Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
CA 1

VAERS 2711744

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge U8135AE

gering
Staat
CA
Alter
70,0
Geschlecht
F
Eingang
08.11.2023
Impfdatum
29.10.2023
Beginn
29.10.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Needle issue No adverse event Underdose

Symptomtext

some of the medication leaked out, not sure if the needle is appropriately put on or not, am not sure the full dose the patient got with no reported adverse event; Initial information received on 29-Oct-2023 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves a 70 years old female patient and pharmacist reported that Influenza Quadrival A-B High Dose Hv Vaccine [Fluzone High-Dose Quadrivalent] leaked out, not sure if the needle is appropriately put on or not, am not sure the full dose the patient got with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 29-Oct-2023, the patient received a 0.7 ml of dose of suspect Influenza Quadrival A-B High Dose Hv Vaccine (strength: high dose, frequency: once, expiry date: unknown and lot U8135AE) via unknown route in unknown administration site as immunization and some of the medication leaked out, not sure if the needle is appropriately put on or not, am not sure the full dose the patient got with no reported adverse event (incorrect dose administered) (same day latency). This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Needle issue
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-